Bestel Elke

Title: Bestel Elke: Innovator in Uterine Fibroid Therapy

Introduction

Bestel Elke is a notable inventor based in Saint-Julien-en-Genevois, France. He has made significant contributions to the field of medical therapy, particularly in the treatment of uterine fibroids. His innovative approach has led to the development of a unique patent that addresses a common health issue faced by many women.

Latest Patents

Bestel Elke holds a patent for "Progesterone receptor modulators for use in the therapy of uterine fibroids." This invention relates to a long-term therapy that includes repeated treatment courses of ulipristal acetate or any metabolite thereof for treating uterine fibroids. Additionally, the patent encompasses a combined therapy that applies ulipristal acetate with a progestin to enhance the effectiveness of current treatments for uterine fibroids.

Career Highlights

Bestel Elke is associated with Preglem SA, a company that focuses on developing innovative therapies for women's health. His work at Preglem has allowed him to contribute to advancements in medical treatments, particularly in gynecology.

Collaborations

He collaborates with notable colleagues such as Osterloh Ian and Loumaye Ernest, who share his commitment to improving women's health through innovative solutions.

Conclusion

Bestel Elke's contributions to the field of uterine fibroid therapy exemplify the impact of innovation in medicine. His patent and work at Preglem SA highlight the importance of ongoing research and development in addressing women's health issues.